Skip to content

Study · Ex vivo tissue · 2002

4 results

[Functional morphology of an organotypic liver culture exposed to the peptide livagen].

Riadnova IIu, Filippov SV, Iuzhakov VV

Advances in gerontology = Uspekhi gerontologii1 Jan 2002

PMID12577697 (opens in a new tab)PepBankPUB-12577697
Publisher pageAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabEx vivo tissueEfficacy outcome

    In liver culture, Livagen stimulated structural and functional homeostasis of cell populations.

    In plain wordsIn lab tests, Livagen stimulated structural and functional stability in liver cell populations.

    Peptide
    Livagen (KEDA)
    Outcome
    IncreaseStructural and functional homeostasis
    Study

    n: not reported in source

    organotypic liver culture
    Outcome group
    Liver fat and liver function · Liver
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Under the data of the immunocytochemical and morphometrical analysis, tetrapeptide stimulates structural and functional homeostasis of cell populations in the liver culture.
    1 context sentence
    Title · context
    [Functional morphology of an organotypic liver culture exposed to the peptide livagen].
  2. 02LabEx vivo tissueEfficacy outcome

    In liver culture, Livagen stabilized morphological preservation.

    In plain wordsIn lab tests, Livagen helped preserve liver cell structure.

    Peptide
    Livagen (KEDA)
    Outcome
    IncreaseMorphological preservation
    Study

    n: not reported in source

    organotypic liver culture
    Outcome group
    Liver fat and liver function · Liver
    Studied dose
    Dose not stated

    Source sentences

    Summary
    It was demonstrated that the main activity of investigated peptide had been directed to the stabilisation of morphological safety and reinforcement of the processes of cellular and intracellular forms of regeneration.
    1 context sentence
    Title · context
    [Functional morphology of an organotypic liver culture exposed to the peptide livagen].
  3. 03LabEx vivo tissueEfficacy outcome

    In liver culture, Livagen reinforced cellular regeneration.

    In plain wordsIn lab tests, Livagen increased cellular regeneration in liver culture.

    Peptide
    Livagen (KEDA)
    Outcome
    IncreaseCellular regeneration
    Study

    n: not reported in source

    organotypic liver culture
    Outcome group
    Liver fat and liver function · Liver
    Studied dose
    Dose not stated

    Source sentences

    Summary
    It was demonstrated that the main activity of investigated peptide had been directed to the stabilisation of morphological safety and reinforcement of the processes of cellular and intracellular forms of regeneration.
    1 context sentence
    Title · context
    [Functional morphology of an organotypic liver culture exposed to the peptide livagen].
  4. 04LabEx vivo tissueEfficacy outcome

    In liver culture, Livagen reinforced intracellular regeneration.

    In plain wordsIn lab tests, Livagen increased regeneration within liver cells.

    Peptide
    Livagen (KEDA)
    Outcome
    IncreaseIntracellular regeneration
    Study

    n: not reported in source

    organotypic liver culture
    Outcome group
    Liver fat and liver function · Liver
    Studied dose
    Dose not stated

    Source sentences

    Summary
    It was demonstrated that the main activity of investigated peptide had been directed to the stabilisation of morphological safety and reinforcement of the processes of cellular and intracellular forms of regeneration.
    1 context sentence
    Title · context
    [Functional morphology of an organotypic liver culture exposed to the peptide livagen].

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 17:05 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.